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ABSTRACT 
Objective: Phytochemical evaluation and in vitro anti-inflammatory activity of stem bark extracts of Mesua ferrea Linn. 
Methods: Petroleum ether, chloroform, and 80% ethanol extracts were used for in-vitro bioassays: such as Human red blood cells membrane 
stabilization, protein inhibitor, inhibition of egg albumin and anti-lipoxygenase assay to evaluate their anti-inflammatory potential. 
Results: Phytochemical analysis revealed the presence of phenols, flavonoids, alkaloids, steroids, saponins, tannins, glycosides, and terpenoids. The 
petroleum ether, chloroform, and 80% ethanol extracts showed significant reduction in inflammation at different 100, 200 and 500μg/ml compared 
to standard drug indomethacin (100μg/ml). 
Conclusion: Based on the results, it can be concluded that the 80% ethanol extract of stem bark of Mesua ferrea Linn. (M. ferrea) exhibited 
significant anti-inflammatory activity compared to petroleum ether and chloroform extracts. 
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INTRODUCTION 
Inflammation is a complex response that protects the host against 
tissue injury and microbial invasion. The redness, swelling, heat, 
pain, and loss of functions are considered as symptoms of 
inflammation. However, prolonged inflammation can be harmful 
contributing to the pathogenesis of many diseases such as asthma, 
arthritis, multiple sclerosis and even cancer [1, 2]. 
Inflammation can be classified as acute and chronic status 
depending on onset time. Acute inflammation is the primary 
response of the body to injurious stimuli and is involved in vascular 
changes i.e. vasodilatation, increased capillary permeability and 
migration of leukocytes. Chronic inflammation is prolonged 
inflammation characterized by progressive destruction and 
retrieving of injured tissue from the inflammatory process [3, 4]. 
Generally, Non-steroidal anti-inflammatory drugs (NSAIDs) are used 
to reduce the pain, inflammation and fever since many years and 
their prolonged use often lead to gastric intolerance, bone marrow 
depression, water and salt retention. Therefore, naturally originated 
agents with fewer adverse effects are desirable to substitute 
chemical therapeutics [5, 6]. 
Mesua ferrea Linn. (Clusiaceae) is a medicinal plant commonly 
known as Nagasampige. It is distributed in tropical countries like 
India, Burma, Thailand, Indochina and New Guinea. Traditionally, 
various parts of Mesua ferrea used for the treatment of inflammation 
related diseases such as skin diseases, wounds, ulcers, hemorrhoids, 
piles and snake bite [7, 8]. Bark and roots are used for the treatment 
of gastritis and bronchitis, buds useful in dysentery, flowers powder 
mixed with ghee applied externally in bleeding piles, leaves as a 
poultice applied on the forehead in severe colds, bark astringent, 
decoction with ginger used as sudorific [7, 9]. The pharmacological 
investigation on Mesua species have shown that they exhibit many 
biological properties such as antioxidant [9, 10], antiulcer [10], 
antimicrobial [11-14], analgesic [15, 16], antibacterial [17], anti-
inflammatory [18, 19], wound healing [20], anti-arthritic [21], 
hepatoprotective [22], antifungal [23], immuno-modulatory [24], 
antispasmodic[25], antineoplastic[26], anti-convulsant [27] and 
antivenom activity [28]. Hence, the present study was carried out to 
evaluate the phytochemical analysis and in vitro anti-inflammatory 
activity of Mesua ferrea Linn. 
MATERIALS AND METHODS 
Drugs and chemicals 
Petroleum ether, chloroform, ethanol and Folin-ciocalteu reagents 
were purchased from Merck (Germany). Gallic acid, quercetin, 
sodium hydroxide, sodium nitrate, aluminum chloride, trypsin, 
perchloric acid and indomethacin were procured from Himedia 
(India). Lipoxidase enzyme and linoleic acid were obtained from 
Sigma-Aldrich (St. Louis, MO, USA). All chemicals used were of 
analytical grade. 
Collection of plant material 
The stem bark of Mesua ferrea Linn. was collected from the Agumbe 
reserve forest area of Western Ghats, Shimoga, Karnataka state, 
India with the permission of forest department (Megaravalli, 
Karnataka). Stem bark material was washed under running tap 
water to remove adhered dirt, followed by rinsing with distilled 
water, shade dried and pulverized in a mechanical grinder to obtain 
coarse powder and stored in an airtight container until use. 
Extraction of the plant material 
About 250 gm of dried powder stem bark of M. ferrea was subjected 
to soxhlation. It was first defatted with petroleum ether then 
sequential extraction with chloroform and 80% ethanol solvent in a 
soxhlet apparatus for 48 h. The temperature was maintained at 50-
60 °C. Extracts were concentrated to dryness by using rotary flash 
evaporator and kept in a desiccator for further use. 
Phytochemical studies 
The preliminary phytochemical screening was performed by using 
standard methods [29, 30]. The presence of phytoconstituents such 
as phenols, flavonoids, alkaloids, steroids, saponins, tannins, 
glycosides and terpenoids were confirmed in stem bark petroleum 
ether, chloroform and 80% ethanol extract..  
Quantitative analysis of stem bark extracts 
Determination of total phenol content 
Total phenol content in petroleum ether, chloroform, and 80% 
ethanol extracts was measured by the Folin–Ciocalteu method of 
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Chang et al.[31]. Briefly, 1 ml of each extract of (100μg) was mixed 
with Folin–Ciocalteu reagent (2 ml) (diluted 1:10, v/v) followed by 
the addition of 2 ml of sodium carbonate (7.5% w/v) and mixed, 
allowed to stand for 90 min. at room temperature and absorbance 
was measured against the blank at 750 nm using a 
spectrophotometer. Total phenol content of the extract was 
expressed in terms of equivalent to Gallic acid. 
Determination of total flavonoids content 
Total flavonoid content of petroleum ether, chloroform, and 80% 
ethanol extracts was determined according to the modified method 
of Zhishen et al., [32]. Briefly, 2.5 ml of extract (100 μg) was mixed 
with 300 μl of 5% sodium nitrite and 300 μl of 10% aluminum 
chloride followed by the addition of 2 ml of 1 M sodium hydroxide 
after the incubation of reaction mixture at room temperature for 6 
min. The volume in each test tube was made up to 10 ml by adding 
2.4 ml of Millipore water. Absorbance was measured at 510 nm 
against the blank. Total flavonoid content of the extract was 
expressed in terms of equivalent to quercetin. 
Evaluation of in vitro anti-inflammatory activity 
Human red blood cells (HRBCs) membrane stabilization method 
The blood was collected from a healthy human volunteer who had 
not taken any NSAIDS for two weeks prior to the experiment and 
mixed with equal volume of Alsever solution (2% dextrose, 0.8% 
sodium citrate, 0.5% citric acid and 0.42% NaCl) and centrifuged at 
3,000 rpm. The packed cells were washed with isosaline,, and a 10% 
suspension was made. Various concentrations of extracts were 
prepared (100, 200 and 500 μg/ml) using distilled water and to each 
concentration, 1 ml of phosphate buffer, 2 ml of hyposaline and 0.5 
ml of HRBC suspension were added. It was incubated at 37 °C for 30 
min. and centrifuged at 3,000 rpm for 20 min. and the hemoglobin 
content of the supernatant solution was estimated using UV 
spectrophotometer at 560 nm. Indomethacin (100μg/ml) was used 
as the reference standard, and control was prepared by omitting the 
extracts [33]. The experiment was performed in triplicates. 
Percentage inhibition of HRBCs membrane stabilization was 
calculated by using the following formula:  
Percent inhibition = [(Acontrol − Atest)/Acontrol] × 100, where Acontrol is 
the absorbance of the control reaction and Atest is the absorbance of 
the control reaction with extract. IC50 value was calculated using the 
formula: IC50 = [(ΣC/ΣI) × 50], where ΣC is the sum of extract 
concentrations used for testing and ΣI is the sum of the percentage 
of inhibition at different concentrations. 
Protein Inhibitory activity 
The test was performed according to the modified method of 
Oyedepo et al.,[34] and Sakat et al., [35]. The reaction mixture of 2 
ml containing 0.06 mg/ml trypsin, 1 ml 20 mM Tris-HCl buffer (pH 
7.4) and 1 ml of test sample of different concentrations (100, 200 
and 500 μg/ml) were incubated at 37 °C for 5 min. and then 1 ml of 
0.8% (w/v) casein was added. The mixture was incubated for an 
additional 20 min. 2 ml of 70% perchloric acid was added to arrest the 
reaction. Cloudy suspension was centrifuged, and the absorbance of 
the supernatant was read at 210 nm against parallel blank. 
The experiment was performed in triplicates. Percentage inhibition of 
protein denaturation was calculated by using the following formula:  
Percent inhibition = [(Acontrol − Atest)/Acontrol] × 100, where Acontrol is 
the absorbance of the control reaction and Atest is the absorbance of 
the control reaction with extract. IC50 value was calculated using the 
formula: IC50 = [(ΣC/ΣI) × 50], where ΣC is the sum of extract 
concentrations used for testing and ΣI is the sum of the percentage 
of inhibition at different concentrations. 
Inhibition of albumin denaturation 
The anti-inflammatory activity of M. ferrea Linn was studied 
inhibition of albumin denaturation technique according to the 
method of Mizushima et al., [36] with minor modifications. The 
reaction mixture consists of test extracts and 1% aqueous solution 
of bovine albumin fraction, pH of the reaction mixture was adjusted 
using a small amount of 1N HCl. The sample extracts were incubated 
at 37 °C for 20 min. and then heated to 51 °C for 20 min. after 
cooling the samples, the turbidity was measured at 660 nm. The 
experiment was performed in triplicates. Percentage of inhibition 
was calculated using the following formula:  
Percent inhibition = [(Acontrol − Atest)/Acontrol] × 100, where Acontrol is 
the absorbance of the control reaction and Atest is the absorbance of 
the control reaction with extract. IC50 value was calculated using the 
formula: IC50 = [(ΣC/ΣI) × 50], where ΣC is the sum of extract 
concentrations used for testing and ΣI is the sum of the percentage 
of inhibition at different concentrations. 
Anti-Lipoxygenase assay 
Anti-lipoxygenase assay was studied using linoleic acid as substrate 
and lipoxidase as an enzyme. The test solution was dissolved in 0.25 
ml of 2M borate buffer pH 9.0 and added 0.25 ml of lipoxidase 
enzyme solution (20,000U/ml) and incubated for 5 min. at 25 °C. 
After which, 1 ml of linoleic acid solution (0.6 mM) was added, 
mixed well and absorbance was measured at 234 nm. Indomethacin 
was used as the reference standard [37]. Percentage inhibition of 
Lipoxygenase assay was calculated by using the following formula: 
Percent inhibition = [(Acontrol − Atest)/Acontrol] × 100, where Acontrol is the 
absorbance of the control reaction and Atest is the absorbance of the 
control reaction with extract. IC50 value was calculated using the 
formula: IC50 = [(ΣC/ΣI) × 50], where ΣC is the sum of extract 
concentrations used for testing and ΣI is the sum of the percentage of 
inhibition at different concentrations. 
Data analysis 
Results are expressed as mean±SEM. The statistical analysis was 
carried out using one-way ANOVA followed by Tukey’s t-test. The 
differences in values at p<0.05 or p<0.01 were considered as 
statistically significant. Statistical analysis was performed by 
ezANOVA 0.98 version. 
RESULTS AND DISCUSSION 
The qualitative screening confirms the presence of phenols, 
flavonoids, alkaloids, steroids, saponins, tannins, glycosides and 
terpenoids (table 1) and the quantitative analysis of stem bark 
extracts has shown, the highest total phenol (58.9 μg/ml) and 
flavonoids content (6.0 μg/ml) in 80% ethanol extract when compared 
to chloroform and petroleum ether extracts is shown in the table 2.  
The above extracts were screened for anti-inflammatory activity 
using various in vitro methods. The prevention of erythrocyte lysis is 
known to be a very good index of anti-inflammatory activity of 
extracts. HRBC membrane is similar to lysosomal membrane 
components. Lysosomal enzymes are being released during 
inflammation produce a variety of disorders which leads to the 
tissue damage and inflammation. The inflammatory responses get 
limited by preventing the release of lysosomal constituents of 
activated neutrophils thereby the damage to the tissue is reduced. 
This extract may inhibit the release of the lysosomal content of 
neutrophils at the site of inflammation [38, 39]. Previous studies 
reported that M. ferrea exhibited significant anti-inflammatory 
activity for HRBCs membrane stabilization, albumin denaturation 
and proteinase inhibitory activity [9]. 
As a result (table 3), HRBC membrane stabilization was effectively 
inhibited by petroleum ether, chloroform and 80% ethanol extracts 
(55.2%, 59.2% and 70.6% respectively) at the concentration of 
500μg/ml and standard drug indomethacin (38.7%) which showed 
significant inhibition at the concentration of 100 μg/ml. IC50 value of 
petroleum ether, chloroform, and 80% ethanol extracts of M. ferrea 
Linn. were found to be 335.2, 309.8 and 247.3 µg/ml respectively. 
Denaturation of proteins is responsible for the cause of 
inflammation. Neutrophils are known to be a rich source of 
proteinases which carry in their lysosomal granules, and it was 
previously reported that leukocytes proteinase plays an important 
role in the development of tissue damage during the inflammatory 
response. Prevention of protein denaturation may also help in 
preventing inflammatory conditions [35, 40]. The inhibitory effect of 
different concentrations (100, 200 and 500 µg/ml) of all the extracts 
of M. ferrea on protein denaturation is shown in table 4. Petroleum 
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ether, chloroform and 80% ethanol extracts (46.4%, 49.1% and 
80.6% respectively)at the concentration of 500 µg/ml and standard 
drug Indomethacin (34%) at the concentration of 100 μg/ml showed 
significant inhibition of protein denaturation when compared with 
control. IC50 value of petroleum ether, chloroform and 80% ethanol 
extracts of M. ferrea were found to be 464.6, 428.7 and 237.8 μg/ml 
respectively. Whereas in albumin denaturation assay (table 5), the 
maximum inhibition (p<0.01) was observed in 80% ethanol extract 
(72.5%) followed by petroleum ether (39.3%) and chloroform 
(38.6%) at the concentration of 500 µg/ml. while the standard drug 
Indomethacin showed 28.8% inhibition at the concentration of 100 
µg/ml. Petroleum ether, chloroform and 80% ethanol extracts of M. 
ferrea Linn. showed IC50 value of 491.5, 488.8 and 217.2 µg/ml 
respectively. 
Anti-lipoxygenase assay was carried out using soybean lipoxidase as an 
enzyme and linoleic acid as a substrate. Lipoxygenase enzyme (LOXs) is 
sensitive to antioxidants and involved in pathophysiology of several 
allergic and inflammatory diseases [41]. Previous studies confirm the 
inhibition of lipoxygenase enzyme can inhibit the synthesis of 
leukotrienes. Leukotrienes are one of the inflammatory mediators 
released from mast cells. They have direct toxic effects which 
phagocytosize the damaged tissue and in the process lead to further 
release of inflammatory mediators [37]. Therefore, inhibition of 
lipoxygenase enzyme by M. ferrea leads to inhibition of synthesis of 
leukotrienes, one of the mechanisms of anti-inflammatory activity [42].  
As shown in table 6, 80% ethanol extract of M. ferrea significantly 
inhibited the enzyme in a concentration-dependent manner. The 
different concentrations of 80% ethanol extract (100, 200 and 500 
µg/ml) exhibited 16.4%, 27.6% and 62.9% inhibition of 
Lipoxygenase enzyme activity respectively. From these results, the 
highest inhibition was observed at the concentration of 500 µg/ml 
when compared with standard drug Indomethacin (53.3% inhibition) 
at the concentration of 100µg/ml. IC50 value of 80% ethanol extract 
and indomethacin was found to be 374.2 and 93.8 µg/ml. 
 
Table 1: Phytochemical analysis of stem bark extracts of Mesua ferrea Linn 
Phytochemical Test Petroleum ether extract Chloroform extract 80% ethanol extract 
Alkaloids + + + 
Flavonoids + + + 
Terpenoids + + + 
Steroids - - + 
Saponins - - + 
Tannins - + + 
Phenolics + + + 
Glycosides + + + 
+= present,-= absent. 
 
Table 2: Quantitative estimation of stem bark extracts of Mesua ferrea Linn 
 Total phenolic content (100 μg/ml) Total flavonoids content (100 μg/ml) 
Petroleum ether extract 18.1 1.0 
Chloroform extract 43.9 2.3 
80%ethanol extract 58.9 6.0  
 
Table 3: Effect of Mesua ferrea Linn on HRBC membrane stabilization 
 Concentration (μg/ml) % inhibition IC50 value 
 Control ----- ----  
335.2 Petroleum ether extract  100 18.6±12.8ns 
 200 45.6±3.6ns 
500 55.2±0.5** 
Chloroform extract 100 27.9±2.9ns  
309.8 200 42.0±3.6ns 
500 59.2±2.0** 
80% ethanol extract 100 43.5±17.9ns  
247.3 200 47.6±3.7* 
500 70.6±4.1 **  
Indomethacin 100 38.7±4.0 129.2 
Each value represents the mean±SD. of triplicates. HRBC membrane stabilization by extracts was compared with standard drug **p<0.01, 
considered extremely significant; *p<0.05, considered significant; ns p>0.05, non-significant. 
 
Table 4: Effect of Mesua ferrea Linn on inhibitory protein assay 
 Concentration (μg/ml) % inhibition IC50  
 Control ----- ------  
464.6 Petroleum ether extract 100 10.9±5.4** 
 200 28.9±2.0ns 
500 46.4±2.7** 
Chloroform extract 100 11.7±2.9**  
428.7 200 32.4±0.8* 
500 49.1±0.3** 
80% ethanol extract 100 36.4±0.1**  
237.8 200 51.2±4.7** 
500 80.6±2.3** 
Indomethacin 100 34.0±9.6 146.9 
Each value represents the mean±SD. of triplicates. Inhibition of protein by extracts compared with standard drug ns p>0.05, non-significant; 
**p<0.01, considered extremely significant; *p<0.05, considered significant. 
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Table 5: Effect of Mesua ferrea Linn on albumin denaturation assay 
 Concentration (μg/ml) % inhibition IC50  
 Control ----- ------  
491.5 Petroleum ether extract 100  8.8±2.1** 
200  33.3±3.1ns 
500 33.3±3.1ns 
Chloroform extract 100 20.2±3.3ns  
488.8 200 29.9±2.7ns 
500 38.6±3.0ns 
80% ethanol extract 100 51.0±3.6*  
217.2 200 60.6±7.1** 
500 72.5±1.7** 
Indomethacin 100 28.8±9.5 173.8 
Each value represents the mean±SD. of triplicates. Inhibition of albumin denaturation by extracts was compared with standard drug ns p>0.05, non-
significant; **p<0.01, considered extremely significant; *p<0.05, considered significant. 
 
Table 6: Effect of Mesua ferrea Linn on anti-Lipoxygenase assay 
 Concentration (μg/ml) % inhibition IC50 value 
Control ----- ----  
 
80% Ethanol extract 
100 16.4±4.1**  
374.2 200 27.6±1.3** 
500 62.9±0.5* 
Indomethacin 100 53.3±0.7 93.8 
Each value represents the mean±SD. of triplicates.  Inhibition of Lipoxygenase by extract was  compared with standard drug **p<0.01, considered 
extremely significant; *p<0.05, considered significant. 
 
CONCLUSION 
Based on the above results, it was concluded that M. ferrea Linn. 
possesses good anti-inflammatory activity which may be due to the 
strong presence of compounds such as phenols, alkaloids, 
flavonoids, tannins, glycosides and terpenoids. This research 
provides the scientific basis for the traditional usage of M. ferrea for 
various inflammatory diseases. However, further studies are 
required for isolation of bioactive compounds for analysis of the 
molecular mechanisms responsible for its anti-inflammatory 
potential and also in vivo anti-inflammatory activity of M. ferrea stem 
bark extract needs to be assessed. 
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